Furthermore, lower Axin expression was shown to correlate with the presence of lymph node metastasis, invasion depth, and lymphatic invasion, implying that decreased Axin levels may contribute to ESCC progression [128]. This evidence concerns the gene AXIN1 and metastatic malignant neoplasm in the lymph nodes.